<DOC>
	<DOCNO>NCT01245751</DOCNO>
	<brief_summary>This study conduct obtain safety immunogenicity data booster dose Zoster Vaccine , Live administer ≥10 year follow initial dose . This information compare similar information obtain Zoster Vaccine , Live administration age-matched young participant receive first dose Zoster Vaccine , Live . The study design determine : 1 ) whether booster dose Zoster Vaccine , Live participant ≥70 year age induce antibody response noninferior first dose Zoster Vaccine , Live participant match age ; 2 ) whether booster dose Zoster Vaccine , Live induce acceptable rise level varicella-zoster virus ( VZV ) antibody .</brief_summary>
	<brief_title>Safety , Tolerability , Immunogenicity Booster Dose Zoster Vaccine , Live ( V211-029 )</brief_title>
	<detailed_description>All participant follow one year completion 42-day post-vaccination period Groups 1 2 follow total three year .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All Groups : Must fever ≥100.4° F day vaccination Any underlying chronic illness must stable condition History varicella residence VZVendemic area ≥30 year Group 1 : 70 year age old Took part Shingles Prevention Study ( SPS ) ( V211004 , NCT00007501 ) receive single dose Zoster Vaccine , Live ≥10 year prior enrollment study Group 2 : 70 year age old Group 3 : 60 69 year age Group 4 : 50 59 year age All Groups : History hypersensitivity reaction vaccine component anaphylactic/anaphylactoid reaction neomycin Prior history herpes zoster Pregnant breastfeeding , expect conceive within duration study Has treat immunoglobulin blood product , autologous ( selfdonated ) blood transfusion , 5 month prior vaccination Received vaccine within 4 week prevaccination On immunosuppressive therapy Has know suspect immune dysfunction Is take nontopical antiviral therapy activity herpesviruses , include , limited acyclovir , famciclovir , valacyclovir , ganciclovir . Groups 2 , 3 , 4 : Has previously receive varicella zoster vaccine</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Shingles</keyword>
	<keyword>Vaccine</keyword>
</DOC>